CAJ

5.56%

38.0¢ capitol health limited

Yes, the IDX board does not like the idea of missing out on...

First 3 Last

Share
Profile

Follow
Rikardo

384 Posts.

14

18/02/18

19:09

Post #: 31141294
Share

Originally posted by Nightwatcher ↑

I share everyone’s frustration re the wasted money on adviser fees.

But what’s fascinating me about all this is the smoke and mirrors. Here is what I’m seeing:

- AFR article on 13/2: IDX confirmed that merger discussions had been held between the parties. The same article reported that it had “emerged Integral chairman Helen Kurincic and chief executive Ian Kadish wrote to their Capitol counterparts in July last year, outlining the benefits and strategic rationale for the tie-up of the two companies”. If that’s true, it sounds like IDX kicked this off, but are now saying its not a good idea??!!

- CAJ refers to the “industrial logic” of the deal: which does make intuitive sense, right? Complementary footprint, scale brings the combined entity up into ASX300, so more funds etc are able to invest, which tends to support the SP, you only need one set of management, you can run better clinical programs etc, etc.

- In this ASX Release, AH comes right out and says: “We have been surprised and frankly greatly disappointed by the intransigence of the Integral Board which has refused to engage constructively with Capitol in order to discuss the merits of a deal.” Big call - he’s historically seemed quite careful about his words, so my money is on him not saying that unless it was true.

- What valid reason could the IDX Board have for refusing to “engage constructively”?

- The IDX SP went up drastically the day that the TO was announced. There’s been very little substance presented so far to support IDX’s statements that the offer doesn’t represent fair value for shareholders.

- There were a few real things in the changes IDX pushed to the original bidders statement, but so much of the rest of it looked like points scoring to me - racking up legal fees on both sides...

Based on the way things seem right now, I know which Board I’d like to send the bill to!

Expand

Yes, the IDX board does not like the idea of missing out on continued remuneration from the Merged Coy. So they will spend/waste their shareholder's money trying to hang on. Sad. But either way CAJ will come out of this OK in my opinion. JMT Rikardo

CAJ Price at posting: 26.5¢ Sentiment: Hold Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

AXP

Tambourah chases gold veins and mineralisation extension with drilling

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

First 3 Last

Add CAJ (ASX) to my watchlist

(20min delay)
Last 38.0¢		Change 0.020(5.56%)		Mkt cap ! $341.1M

Open	High	Low	Value	Volume
36.5¢	38.0¢	36.5¢	$366.6K	980.1K

Buyers (Bids)

No.	Vol.	Price($)
1	1394	37.0¢

Sellers (Offers)

Price($)	Vol.	No.
38.0¢	193185	6

View Market Depth

No.	Vol.	Price($)
5	335146	0.205
4	294750	0.200
9	662563	0.195
7	1086315	0.190
4	104210	0.185

Price($)	Vol.	No.
0.215	360292	5
0.220	318014	13
0.225	188194	5
0.230	1008000	2
0.235	45245	2

Last trade - 16.10pm 25/11/2024 (20 minute delay)

CAJ (ASX) Chart

Yes, the IDX board does not like the idea of missing out on...

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Tambourah chases gold veins and mineralisation extension with drilling

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Yes, the IDX board does not like the idea of missing out on...

Top Stories

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Tambourah chases gold veins and mineralisation extension with drilling

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News